Cytek Biosciences, Inc. CTKB

CTKB Company Overview

Cytek Biosciences, Inc. is a U.S.-based life sciences technology company focused on advanced cell analysis instruments and related consumables for biomedical research and clinical applications. The company operates primarily within the flow cytometry and cell analysis markets, serving academic research institutions, pharmaceutical and biotechnology companies, clinical laboratories, and government research organizations. Cytek is best known for its full spectrum flow cytometry technology, which captures and analyzes the complete emission spectra of fluorochromes to improve multiplexing capability and cellular analysis performance compared with conventional flow cytometry systems.

Cytek’s principal revenue drivers include sales of flow cytometry instruments, recurring consumables and reagents, software solutions, and service contracts. Its flagship platforms include the Aurora and Northern Lights systems, alongside imaging and sample preparation technologies acquired through strategic transactions. The company traces its origins to 2006 and expanded significantly following the commercialization of spectral flow cytometry platforms and its 2021 public listing on Nasdaq under the ticker CTKB. Cytek has positioned itself as a differentiated provider in high-parameter cell analysis through proprietary optical designs, integrated software, and a growing installed base that supports recurring revenue generation.